{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:04:35Z","timestamp":1759017875702,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.clinthera.2011.11.007","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T23:39:01Z","timestamp":1323301141000},"page":"1953-1963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparative Efficacy and Safety Profile of Amlodipine 5 mg\/Losartan 50 mg Fixed-Dose Combination and Amlodipine 10 mg Monotherapy in Hypertensive Patients Who Respond Poorly to Amlodipine 5 mg Monotherapy: An 8-Week, Multicenter, Randomized, Double-Blind Phase III Noninferiority Study"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct00940667","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Seok-Min","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Chan","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shung Chull","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Young","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moo Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taek Jong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Gu","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Han","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Yun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.11.007_bib1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2011.11.007_bib2","first-page":"S4","article-title":"Standards of medical care in diabetes\u20142006","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2011.11.007_bib3","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1016\/j.amjhyper.2003.07.004","article-title":"Are there benefits to specific antihypertensive drug therapy?","volume":"16","author":"Cushman","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2011.11.007_bib4","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.11.007_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.11.007_bib6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0149-2918(97)80011-2","article-title":"Comparative efficacy and tolerability of two long-acting calcium antagonists, mibefradil and amlodipine, in essential hypertension","volume":"19","author":"Karch","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.11.007_bib7","first-page":"1264","article-title":"Rationale for the use of a fixed-dose combination in the management of hypertension : efficacy and tolerability of lercanidipine\/enalapril","volume":"33","author":"Borghi","year":"2010","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2011.11.007_bib8","first-page":"207","article-title":"Efficacy and safety of losartan-amplodipine combination\u2014an Indian postmarketing surveillance experience","volume":"100","author":"Gokhale","year":"2002","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.clinthera.2011.11.007_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.11.007_bib10","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1001\/archinte.161.22.2661","article-title":"A practical approach to achieving recommended blood pressure goals in diabetic patients","volume":"161","author":"Bakris","year":"2001","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2011.11.007_bib11","first-page":"S17","article-title":"Evaluation and quality-of-life assessment of amlodipine and enalapril in patients with hypertension","volume":"9","author":"Omvik","year":"1995","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.clinthera.2011.11.007_bib12","first-page":"23","article-title":"A long-term, double-blind, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study","volume":"73","author":"Omvik","year":"1994","journal-title":"Br J Clin Pract Suppl"},{"key":"10.1016\/j.clinthera.2011.11.007_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0149-2918(96)80212-8","article-title":"Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension","volume":"18","author":"Oparil","year":"1996","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.11.007_bib14","first-page":"39","article-title":"[The \u201cLOTHAR\u201d study: evaluation of efficacy and tolerability of the fixed combination of amlodipine and losartan in the treatment of essential hypertension]","volume":"86","author":"Kohlmann","year":"2006","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.clinthera.2011.11.007_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0011-393X(98)85035-2","article-title":"Efficacy, safety, and effects on hypertension-associated symptoms of losartan, alone or in combination with hydrochlorothiazide, versus amlodipine in patients with mild-to-moderate hypertension","volume":"59","author":"Tiebel","year":"1998","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.clinthera.2011.11.007_bib16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2011.11.007_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0149-2918(04)90071-9","article-title":"Randomized, open-label, two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects","volume":"26","author":"Park","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.11.007_bib18","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.clinthera.2007.09.018","article-title":"Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension","volume":"29","author":"Kim","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.11.007_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641960902960532","article-title":"The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm","volume":"32","author":"Schmieder","year":"2010","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.clinthera.2011.11.007_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.clinthera.2008.04.002","article-title":"The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study","volume":"30","author":"Chrysant","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.11.007_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clinthera.2007.03.018","volume":"29","author":"Philipp","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.11.007_bib22","unstructured":"Park C, Youn H, Chae S, et al. An 8-week, multicenter, randomized, double-blind, factorial phase II study to evaluate dose-response relationship of amlodipine and losartan combination in patients with essential hypertension. Am J Cardiovasc Drugs. In press."},{"key":"10.1016\/j.clinthera.2011.11.007_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(10)62003-X","article-title":"Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial","volume":"377","author":"Brown","year":"2011","journal-title":"Lancet"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:49:01Z","timestamp":1758962941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811007247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0149291811007247"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.11.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Efficacy and Safety Profile of Amlodipine 5 mg\/Losartan 50 mg Fixed-Dose Combination and Amlodipine 10 mg Monotherapy in Hypertensive Patients Who Respond Poorly to Amlodipine 5 mg Monotherapy: An 8-Week, Multicenter, Randomized, Double-Blind Phase III Noninferiority Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier HS Journals, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}